| Hans-Günter Meyer-Thompson | International
The effect of craving on retention and treatment switching under buprenorphine-naloxone and methadone models of care for non-heroin opioid use disorder: Exploratory analyses from a pragmatic, randomized controlled trial.
The effect of craving on retention and treatment switching under buprenorphine-naloxone and methadone models of care for non-heroin opioid use disorder: Exploratory analyses from a pragmatic, randomized controlled trial.
McAnulty C, Bastien G, Abboud A, Bahremand A, Ledjiar O, Socias ME, Le Foll B, Juteau LC, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse.
J Subst Use Addict Treat. 2025 Jun 24;176:209743. doi: 10.1016/j.josat.2025.209743. Epub ahead of print. PMID: 40571059.